MR1 and neoplasm: In biodistribution studies using athymic nude mice bearing subcutaneous EGFRvIII-expressing U87 tumor xenografts, an up to 244 ± 77% increase in tumor uptake for MR1-1(Fv)-PE38 was observed compared with that for MR1(Fv)-PE38 [67].